Fig. 12
SwissADME interpreted that the indirubin AI enhanced lead will penetrate the Blood-Brain Barrier (BBB) and Gastrointestinal tract, as represented by the red dot.
Fig. 12 | Scientific Reports
SwissADME interpreted that the indirubin AI enhanced lead will penetrate the Blood-Brain Barrier (BBB) and Gastrointestinal tract, as represented by the red dot.
